Skip to main content

Peer Review reports

From: Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide

Original Submission
27 Sep 2022 Submitted Original manuscript
17 Dec 2022 Reviewed Reviewer Report - Xun Shangguan
26 Jan 2023 Reviewed Reviewer Report
9 Feb 2023 Author responded Author comments - Yasuhide Miyoshi
Resubmission - Version 2
9 Feb 2023 Submitted Manuscript version 2
10 Feb 2023 Author responded Author comments - Yasuhide Miyoshi
Resubmission - Version 3
10 Feb 2023 Submitted Manuscript version 3
15 Feb 2023 Reviewed Reviewer Report
15 Feb 2023 Reviewed Reviewer Report - Xun Shangguan
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Mar 2023 Editorially accepted
7 Mar 2023 Article published 10.1186/s12885-023-10700-0

You can find further information about peer review here.

Back to article page